|

Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours

RECRUITINGN/ASponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
PhaseN/A
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2023-04-27
Est. completion2026-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06729944

Summary

The aim of this study is to identify a dysplasia- and CCA-specific NGS panel to increase the diagnostic sensitivity of histological and/or cytological examination of biliary tract stenosis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Availability of enough tissue for histological and NGS analysis (at least 20 ng DNA).
* Age greater than/equal to 18 years.

Exclusion Criteria:

* None

Conditions4

CancerHepatectomyNGSStenosis of Bile Duct

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.